Xerecept Intravenous Dose Escalation in Japanese and Caucasian Volunteers
NCT00820092
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
38
Enrollment
INDUSTRY
Sponsor class
Conditions
Edema
Interventions
DRUG:
Xerecept 1.0
DRUG:
Xerecept 2.0
DRUG:
Xerecept 3.0
Sponsor
Celtic Pharma Development Services